Cancer stem cells - important players in tumor therapy resistance

Author:

Colak Selcuk1,Medema Jan P.1

Affiliation:

1. LEXOR (Laboratory of Experimental Oncology and Radiobiology); Center for Experimental Molecular Medicine and Cancer Genomics Center; Academic Medical Center; University of Amsterdam; The Netherlands

Funder

Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Alpe dHuzes/KWF

Dutch Cancer Society

MLDS

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference117 articles.

1. National Cancer Act of 1971 - an editorial;Weinhouse;Cancer Res,1972

2. Ferlay J Soerjomataram I Ervik M Dikshit R Eser S Mathers C Rebelo M Parkin DM Forman DBF 2013 GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] International Agency for Research on Cancer Lyon, France http://globocan.iarc.fr

3. Cancer drug resistance: an evolving paradigm;Holohan;Nat Rev Cancer,2013

4. Multidrug resistance in cancer: role of ATP-dependent transporters;Gottesman;Nat Rev Cancer,2002

5. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells;Clarke;Cancer Res,2006

Cited by 209 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3